Table 1:
Pre-operative Patient Characteristics
| Group 1 (HM3) (n=19) |
Group 2 (n=85) |
p-value | |
|---|---|---|---|
| CHF Etiology | |||
| ICMP | 9 (47.4%) | 42 (49.4%) | 0.99 |
| NICMP | 10 (52.6%) | 43 (50.6%) | |
| Age | |||
| Mean ± (SD) | 56.8 (13.1) | 59.6 (12.4) | 0.34 |
| Female | 8 (42.1%) | 23 (27.1%) | 0.27 |
| BMIa | |||
| Mean ± (SD) | 37.0 (8.9) | 31.6 (7.34) | 0.01 |
| Chronic Lung Disease | 7 (36.8%) | 17 (20.0%) | 0.14 |
| CVA History | 4 (21.1%) | 21 (24.7%) | 0.99 |
| Ventilator | 1 (5.3%) | 15 (17.6%) | 0.29 |
| IV Inotropes | 2 (14.3%) | 13 (30.2%) | 0.31 |
| Creatinine | |||
| Median [Min, Max] | 1.20 [0.700, 2.40] | 1.40 [0.600, 6.30] | 0.09 |
| Bilirubin | |||
| Median [Min, Max] | 1.40 [0.500, 5.30] | 1.40 [0.400, 19.5] | 0.56 |
| Plasma Free Hbb | |||
| Median [Min, Max] | 26 [8.00, 517] | 38.0 [5.00, 917] | 0.95 |
| LDHb | |||
| Median [Min, Max] | 920 [214, 2580] | 781 [173, 11200] | 0.93 |
| Number of Previous LVAD | <0.001 | ||
| 1 | 10 (52.6%) | 77 (91.8%) | |
| 2 | 7 (36.8%) | 6 (5.9%) | |
| 3 | 2 (10.5%) | 2 (2.4%) | |
| Number of Previous Sternotomies | 0.001 | ||
| 1 | 5 (26.3%) | 56 (65.9%) | |
| 2 | 8 (42.1%) | 23 (27.1%) | |
| 3 | 6 (31.6%) | 6 (7.1%) | |
| Indication for replacement | 0.21 | ||
| Malfunction | 3 (15.8%) | 19 (22.4%) | |
| Infection | 2 (10.5%) | 23 (27.1%) | |
| Thrombosis | 14 (73.7%) | 43 (50.6%) | |
| Duration of Explanted LVAD Supportc | |||
| Median [Min, Max] | 456 [39.0, 2400] | 456 [2.00, 1930] | 0.66 |
BMI, body mass index; CHF, congestive heart failure; CVA, cerebrovascular accident; Hb, hemoglobin; ICMP, ischemic cardiomyopathy; LDH, lactate dehydrogenase; LVAD, left ventricular assist device; NICMP, non-ischemic cardiomyopathy; NYHA, New York Heart Association; RV, right ventricle; SD, standard deviation;
a
kg/m2;
b
mg/dL;
c
days